Greylin Investment Mangement Inc United Therapeutics Corp Transaction History

Greylin Investment Mangement Inc

  • $566 Million
  • Q2 2024

A detailed history of Greylin Investment Mangement Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Greylin Investment Mangement Inc holds 1,350 shares of UTHR stock, worth $490,387. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,350
Previous 1,425 5.26%
Holding current value
$490,387
Previous $327,000 31.5%
% of portfolio
0.08%
Previous 0.06%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024
SELL
$228.26 - $319.04 $17,119 - $23,928
-75 Reduced 5.26%
1,350 $430,000
Q1 2024

Apr 24, 2024
SELL
$210.76 - $249.51 $5,269 - $6,237
-25 Reduced 1.72%
1,425 $327,000
Q4 2023

Jan 25, 2024
SELL
$214.88 - $256.94 $26,860 - $32,117
-125 Reduced 7.94%
1,450 $318,000
Q2 2023

Jul 10, 2023
SELL
$205.19 - $232.99 $82,076 - $93,196
-400 Reduced 20.25%
1,575 $347,000
Q1 2023

Apr 07, 2023
SELL
$212.99 - $276.17 $63,897 - $82,851
-300 Reduced 13.19%
1,975 $442,000
Q4 2022

Jan 25, 2023
SELL
$205.95 - $280.43 $15,446 - $21,032
-75 Reduced 3.19%
2,275 $0
Q3 2022

Oct 13, 2022
SELL
$203.3 - $244.17 $10,165 - $12,208
-50 Reduced 2.08%
2,350 $492,000
Q2 2022

Jul 11, 2022
SELL
$174.81 - $241.14 $26,221 - $36,171
-150 Reduced 5.88%
2,400 $566,000
Q1 2022

May 20, 2022
SELL
$166.16 - $213.96 $1.15 Million - $1.47 Million
-6,891 Reduced 72.99%
2,550 $457,000
Q4 2021

Feb 15, 2022
SELL
$184.32 - $216.08 $20,459 - $23,984
-111 Reduced 1.16%
9,441 $2.04 Million
Q3 2021

Oct 13, 2021
SELL
$179.86 - $214.88 $838,147 - $1 Million
-4,660 Reduced 32.79%
9,552 $1.76 Million
Q2 2021

Jul 14, 2021
SELL
$170.47 - $211.93 $3.07 Million - $3.82 Million
-18,024 Reduced 55.91%
14,212 $2.55 Million
Q1 2021

May 12, 2021
SELL
$153.94 - $174.85 $552,336 - $627,361
-3,588 Reduced 10.02%
32,236 $5.39 Million
Q4 2020

Jan 14, 2021
SELL
$101.87 - $151.79 $1.77 Million - $2.64 Million
-17,365 Reduced 32.65%
35,824 $5.44 Million
Q3 2020

Oct 13, 2020
SELL
$99.9 - $121.13 $6.19 Million - $7.51 Million
-61,979 Reduced 53.82%
53,189 $5.37 Million
Q2 2020

Aug 13, 2020
SELL
$92.74 - $125.82 $1.74 Million - $2.36 Million
-18,755 Reduced 14.0%
115,168 $13.9 Million
Q1 2020

Apr 09, 2020
SELL
$79.39 - $115.35 $1.85 Million - $2.69 Million
-23,293 Reduced 14.82%
133,923 $12.7 Million
Q4 2019

Jan 09, 2020
SELL
$78.31 - $95.34 $1.6 Million - $1.95 Million
-20,445 Reduced 11.51%
157,216 $13.8 Million
Q3 2019

Oct 11, 2019
BUY
$74.85 - $85.99 $2.9 Million - $3.33 Million
38,683 Added 27.83%
177,661 $14.2 Million
Q2 2019

Aug 15, 2019
BUY
$76.06 - $120.81 $1.61 Million - $2.56 Million
21,200 Added 18.0%
138,978 $10.8 Million
Q1 2019

Apr 09, 2019
SELL
$107.15 - $126.84 $323,057 - $382,422
-3,015 Reduced 2.5%
117,778 $13.8 Million
Q4 2018

Jan 14, 2019
BUY
$101.4 - $128.73 $12.2 Million - $15.5 Million
120,793 New
120,793 $13.2 Million
Q3 2018

Nov 14, 2018
SELL
$113.81 - $129.46 $13.5 Million - $15.4 Million
-118,703 Closed
0 $0
Q2 2018

Aug 07, 2018
BUY
$101.14 - $118.31 $8.09 Million - $9.47 Million
80,006 Added 206.75%
118,703 $13.4 Million
Q1 2018

May 14, 2018
BUY
$107.21 - $151.94 $4.15 Million - $5.88 Million
38,697 New
38,697 $4.35 Million
Q4 2017

Jan 16, 2018
SELL
$118.58 - $151.28 $400,207 - $510,570
-3,375 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$114.6 - $136.81 $386,775 - $461,733
3,375
3,375 $396,000

Others Institutions Holding UTHR

# of Institutions
667
Shares Held
42.7M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Greylin Investment Mangement Inc Portfolio

Follow Greylin Investment Mangement Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greylin Investment Mangement Inc, based on Form 13F filings with the SEC.

News

Stay updated on Greylin Investment Mangement Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email